Annual EBIT
-$102.56 M
-$40.53 M-65.34%
31 December 2023
Summary:
Terns Pharmaceuticals annual earnings before interest & taxes is currently -$102.56 million, with the most recent change of -$40.53 million (-65.34%) on 31 December 2023. During the last 3 years, it has fallen by -$65.53 million (-177.00%). TERN annual EBIT is now -455.72% below its all-time high of -$18.39 million.TERN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$24.94 M
+$598.00 K+2.34%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly earnings before interest & taxes is currently -$24.94 million, with the most recent change of +$598.00 thousand (+2.34%) on 30 September 2024. Over the past year, it has increased by +$8.24 million (+24.85%). TERN quarterly EBIT is now -185.44% below its all-time high of -$8.74 million, reached on 30 September 2020.TERN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$99.98 M
+$8.24 M+7.62%
30 September 2024
Summary:
Terns Pharmaceuticals TTM earnings before interest & taxes is currently -$99.98 million, with the most recent change of +$8.24 million (+7.62%) on 30 September 2024. Over the past year, it has dropped by -$4.65 million (-4.88%). TERN TTM EBIT is now -905.43% below its all-time high of -$9.94 million, reached on 31 December 2019.TERN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.3% | +24.9% | -4.9% |
| 3 y3 years | -177.0% | -110.1% | -123.4% |
| 5 y5 years | -455.7% | - | - |
TERN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -177.0% | at low | -110.1% | +24.9% | -123.4% | +7.6% |
| 5 y | 5 years | -455.7% | at low | -185.4% | +24.9% | -905.4% | +7.6% |
| alltime | all time | -455.7% | at low | -185.4% | +24.9% | -905.4% | +7.6% |
Terns Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.94 M(-2.3%) | -$99.98 M(-7.6%) |
| June 2024 | - | -$25.54 M(+0.4%) | -$108.22 M(+4.2%) |
| Mar 2024 | - | -$25.45 M(+5.8%) | -$103.85 M(+1.3%) |
| Dec 2023 | -$102.56 M(+65.3%) | -$24.06 M(-27.5%) | -$102.56 M(+7.6%) |
| Sept 2023 | - | -$33.18 M(+56.8%) | -$95.33 M(+20.0%) |
| June 2023 | - | -$21.16 M(-12.4%) | -$79.44 M(+9.8%) |
| Mar 2023 | - | -$24.16 M(+43.6%) | -$72.36 M(+16.7%) |
| Dec 2022 | -$62.03 M | -$16.83 M(-2.7%) | -$62.03 M(+5.0%) |
| Sept 2022 | - | -$17.29 M(+22.8%) | -$59.08 M(+10.1%) |
| June 2022 | - | -$14.08 M(+1.9%) | -$53.66 M(+6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.82 M(-0.4%) | -$50.39 M(+1.1%) |
| Dec 2021 | -$49.86 M(+34.7%) | -$13.88 M(+16.9%) | -$49.86 M(+11.4%) |
| Sept 2021 | - | -$11.87 M(+9.7%) | -$44.75 M(+7.5%) |
| June 2021 | - | -$10.82 M(-18.6%) | -$41.62 M(+1.8%) |
| Mar 2021 | - | -$13.30 M(+51.6%) | -$40.90 M(+10.5%) |
| Dec 2020 | -$37.02 M(-47.3%) | -$8.77 M(+0.4%) | -$37.02 M(-3.1%) |
| Sept 2020 | - | -$8.74 M(-13.5%) | -$38.20 M(+29.7%) |
| June 2020 | - | -$10.10 M(+7.2%) | -$29.46 M(+52.1%) |
| Mar 2020 | - | -$9.42 M(-5.2%) | -$19.37 M(+94.8%) |
| Dec 2019 | -$70.20 M(+280.4%) | -$9.94 M | -$9.94 M |
| Dec 2018 | -$18.45 M | - | - |
FAQ
- What is Terns Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual EBIT year-on-year change?
- What is Terns Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly EBIT year-on-year change?
- What is Terns Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals TTM EBIT year-on-year change?
What is Terns Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of TERN is -$102.56 M
What is the all time high annual EBIT for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual earnings before interest & taxes is -$18.39 M
What is Terns Pharmaceuticals annual EBIT year-on-year change?
Over the past year, TERN annual earnings before interest & taxes has changed by -$40.53 M (-65.34%)
What is Terns Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of TERN is -$24.94 M
What is the all time high quarterly EBIT for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$8.74 M
What is Terns Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, TERN quarterly earnings before interest & taxes has changed by +$8.24 M (+24.85%)
What is Terns Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of TERN is -$99.98 M
What is the all time high TTM EBIT for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high TTM earnings before interest & taxes is -$9.94 M
What is Terns Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, TERN TTM earnings before interest & taxes has changed by -$4.65 M (-4.88%)